Stay updated on Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page
- Check4 days agoChange DetectedThe page footer now displays Revision: v3.6.2, reflecting a platform version update for the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedEnrollment status on the study page indicates recruitment is closed. New sections for reading the study record, common questions, and joining a study were added to guide users, and a formatting tweak adjusts the Intervention/Treatment header along with a revision label.SummaryDifference0.3%

- Check26 days agoChange DetectedRenamed the study location from Jilin, China, 130021 to Jilin City, China, 130021, and updated the page revision from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision line now shows v3.5.4 and the previous v3.5.3 entry is removed, indicating a minor update to the page's version history.SummaryDifference0.0%

- Check62 days agoChange DetectedThe location entry Taoyuan District, Taiwan, 33305 was updated to Taoyuan, Taiwan, 33305 in the locations list. This reflects a change in the geographic designation of that site.SummaryDifference0.0%

- Check69 days agoChange DetectedThis update reflects a minor ClinicalTrials.gov page/version revision change (from v3.5.2 to v3.5.3) without any change to the underlying study details.SummaryDifference0.0%

Stay in the know with updates to Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.